ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
| Project Title | Institution / Principal Investigator(s) | Grant Type |
Year |
State |
|---|---|---|---|---|
| Exploiting a Novel DNA Repair Defect in Ewing Sarcoma | Dana-Farber Cancer Institute / Shuhei Asada, MD/PhD | Young Investigator Grants | 2024 | Massachusetts |
| Investigating the impact of osteosarcoma genetic lesions on bone differentiation | Dana-Farber Cancer Institute / James Morrow, MD/PhD | Young Investigator Grants | 2024 | Massachusetts |
| Improving homing and activity of CAR T cells in pediatric sarcomas | University of Colorado Denver / Joselyn Cruz Cruz, PhD | Young Investigator Grants | 2024 | Colorado |
| Defining how unique properties of the pediatric immune system contribute to poor efficacy of checkpoint blockade in children | Stanford University / Adrienne Long, MD/PhD | Young Investigator Grants | 2024 | California |
| Understanding the role of CDK8 in protein synthesis for treating MYC-driven medulloblastoma | University of Colorado Denver / Dong Wang, PhD | Young Investigator Grants | 2024 | Colorado |
| Empowering specificity of AML immunotherapies by HSC engineering | Aflac Cancer Center and Blood Disorders Service of Children’s Healthcare of Atlanta / Pietro Genovese | Catalyst Grants | 2023 | Georgia |
| Immunoglobulin High-Throughput Sequencing for Refining Risk Stratification in Infant B-ALL | University of Rochester / Carol Fries Simpson, MD | Reach Grants | 2023 | New York |
| Identification of Aberrantly Methylated Differentially Expressed Genes to Distinguish High- vs. Low-Risk Retinoblastoma | Children’s Hospital Los Angeles / Jesse Berry, MD | Reach Grants | 2023 | California |
| Mechanisms to Redirect Tumor Associated Macrophages to Target Retinoblastoma Cells | The Regents of the University of Minnesota / Timothy Hallstrom, PhD | Innovation Grants | 2023 | Minnesota |
| Targeting Chromatin Remodeling Complexes for Rhabdomyosarcoma (RMS) Therapy | Dana-Farber Cancer Institute / Jun Qi, PhD | Innovation Grants | 2023 | Massachusetts |